Verizon Officer Kyle Malady Files Form 144 to Sell 1,100 Shares Under Rule 10b5-1 Plan
VERIZON COMMUNICATIONS INC
Subscribe to track VZ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Form 144 Filed: Verizon Communications Inc. ($VZ) š¤ Insider: Kyle Malady (Officer) š Approx. Sale Date: 10/20/2026 š¦ Shares to Sell: 1,100 Common Shares š° Aggregate Market Value: $48,928.00 (~$44.48/share) š Trading Plan: Rule 10b5-1 adopted on 05/18/2026 āļø Significance: Low (Routine programmatic sale)
Comprehensive Analysis
Executive Summary
On October 20, 2026, Kyle Malady, an Officer of Verizon Communications Inc. ($VZ), filed a Form 144 notifying the proposed sale of 1,100 shares of common stock through Fidelity Brokerage Services LLC. The aggregate market value of the proposed transaction is $48,928.00, representing an estimated price of approximately $44.48 per share.
Transaction & Plan Details
- Security: Common Stock
- Proposed Sale Date: October 20, 2026
- Shares Proposed for Sale: 1,100
- Aggregate Market Value: $48,928.00
- Acquisition Origin: The shares were acquired on March 1, 2026, via restricted stock unit (RSU) vesting as equity compensation from the issuer.
- Rule 10b5-1 Plan: The transaction is part of a pre-arranged Rule 10b5-1 trading plan adopted on May 18, 2026.
- Prior 3-Month Activity: The insider has executed recurring weekly sales of 1,100 shares from mid-August through mid-October 2026, consistent with an automated trading schedule.
Market Impact & Significance
The trading significance of this filing is assessed as Low. The proposed disposition represents an infinitesimal fraction of Verizon's 4.15 billion common shares outstanding and is executed under a structured Rule 10b5-1 plan established months in advance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
